Australia markets closed

ANI Pharmaceuticals, Inc. (ANIP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
67.25+0.14 (+0.21%)
At close: 04:00PM EDT
67.25 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.41B
Enterprise value 1.50B
Trailing P/E 78.91
Forward P/E 14.77
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.51
Price/book (mrq)3.25
Enterprise value/revenue 3.07
Enterprise value/EBITDA 14.04

Trading information

Stock price history

Beta (5Y monthly) 0.80
52-week change 371.46%
S&P500 52-week change 322.43%
52-week high 370.81
52-week low 337.87
50-day moving average 366.20
200-day moving average 359.05

Share statistics

Avg vol (3-month) 3145.39k
Avg vol (10-day) 3106.3k
Shares outstanding 520.98M
Implied shares outstanding 620.98M
Float 815.09M
% held by insiders 111.20%
% held by institutions 176.22%
Shares short (15 Apr 2024) 4213.52k
Short ratio (15 Apr 2024) 41.29
Short % of float (15 Apr 2024) 41.32%
Short % of shares outstanding (15 Apr 2024) 41.02%
Shares short (prior month 15 Mar 2024) 4261.6k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:6
Last split date 318 July 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 3.86%
Operating margin (ttm)6.62%

Management effectiveness

Return on assets (ttm)3.72%
Return on equity (ttm)4.72%

Income statement

Revenue (ttm)486.82M
Revenue per share (ttm)27.04
Quarterly revenue growth (yoy)39.70%
Gross profit (ttm)N/A
EBITDA 109.32M
Net income avi to common (ttm)15.47M
Diluted EPS (ttm)0.85
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)221.12M
Total cash per share (mrq)11.22
Total debt (mrq)291.34M
Total debt/equity (mrq)63.67%
Current ratio (mrq)3.57
Book value per share (mrq)22.64

Cash flow statement

Operating cash flow (ttm)118.96M
Levered free cash flow (ttm)112.78M